España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Galapagos
GLPG
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Galapagos (GLPG) Forecast
News
Earnings
Galapagos (GLPG) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Galapagos (NASDAQ:GLPG) Stock
Galapagos Stock (NASDAQ: GLPG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 01, 2024
RBC Capital Maintains Sector Perform on Galap...
Benzinga Newsdesk
Wednesday, October 30, 2024
Galapagos Q3 2024 GAAP EPS $(0.34) Misses $(0...
Benzinga Newsdesk
Tuesday, October 01, 2024
Excellos, Cell Therapy Contract And Developme...
Benzinga Newsdesk
Monday, September 30, 2024
Galapagos Receives Transparency Notification ...
Benzinga Newsdesk
Monday, September 16, 2024
Galapagos Receives Transparency Notification ...
Benzinga Newsdesk
Monday, September 09, 2024
Leerink Partners Initiates Coverage On Galapa...
Benzinga Newsdesk
Tuesday, August 27, 2024
Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, August 26, 2024
Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities'
Vandana Singh
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Galapagos shares are trading higher after Eco...
Benzinga Newsdesk
Ecor1 Capital Reported A 9.9% Stake In Galapa...
Benzinga Newsdesk
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, August 23, 2024
Galapagos Gets FDA Nod For IND Application On...
Benzinga Newsdesk
Tuesday, August 20, 2024
Galapagos Receives Transparency Notification ...
Benzinga Newsdesk
Friday, August 02, 2024
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
Vandana Singh
Thursday, August 01, 2024
Galapagos Q2 2024 Adj EPS $1.51 Beats $(0.04)...
Benzinga Newsdesk
BridGene Biosciences Expands Collaboration Wi...
Benzinga Newsdesk
Friday, June 14, 2024
Galapagos To Present Data On CD19 CAR-T Candi...
Benzinga Newsdesk
Thursday, May 30, 2024
Galapagos And Adaptimmune Enter Clinical Coll...
Benzinga Newsdesk
Wednesday, May 15, 2024
Galapagos And Blood Centers Of America Collab...
Benzinga Newsdesk
Thursday, May 02, 2024
Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Revenue ...
Benzinga Newsdesk
Monday, April 22, 2024
Morgan Stanley Maintains Equal-Weight on Gala...
Benzinga Newsdesk
Thursday, April 04, 2024
Galapagos Plans Clinical And Translational Da...
Benzinga Newsdesk
Monday, April 01, 2024
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
Vandana Singh
B of A Securities Downgrades Galapagos to Und...
Benzinga Newsdesk
Thursday, March 28, 2024
B of A Securities Downgrades Galapagos to Und...
Benzinga Newsdesk
Thursday, March 07, 2024
Morgan Stanley Assumes Galapagos at Equal-Wei...
Benzinga Newsdesk
Friday, February 23, 2024
Galapagos shares are trading lower following ...
Benzinga Newsdesk
Thursday, February 22, 2024
Galapagos Expects FY24 Further Reduction In C...
Benzinga Newsdesk
Galapgos FY23 EPS €3.21 Up From €(3.32) YoY R...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Friday, February 16, 2024
Galapagos To Present New Preliminary Translat...
Benzinga Newsdesk
Thursday, January 04, 2024
Galapagos Enters Strategic Collaboration Deal...
Benzinga Newsdesk
Wednesday, January 03, 2024
European Drugmaker Galapagos Collaborates With Biotech BridGene Biosciences To Develop Cancer Treatments
Vandana Singh
BridGene Says "Galapagos Will Pay Up To $27M ...
Benzinga Newsdesk
BridGene Biosciences Announces Strategic Coll...
Benzinga Newsdesk
Tuesday, January 02, 2024
B of A Securities Maintains Neutral on Galapa...
Benzinga Newsdesk
Galapagos Transforms Into Biotech Innovator, ...
Benzinga Newsdesk
Tuesday, December 19, 2023
Galapagos NV Announced That The First Patient...
Benzinga Newsdesk
Saturday, December 09, 2023
Galapagos To Present New Data At Ash 2023 From Ongoing CD19 Car-t Studies With GLPG5201 And GLPG5101
Charles Gross
Thursday, November 02, 2023
Galapagos Reiterates 2023 Net Jyseleca Sales ...
Benzinga Newsdesk
Galapagos 9-Month Total Net Revenues Up 9% To...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Monday, October 30, 2023
Galapagos Concludes Strategic Evaluation And ...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Galapagos Says First patient Randomized In GA...
Benzinga Newsdesk
Galapagos Announces Start Of Phase 2 Study Wi...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch